{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:12:27Z","timestamp":1785798747292,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.atherosclerosis.2013.11.069","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T10:02:04Z","timestamp":1387533724000},"page":"3-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Leptin and coronary heart disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"233","author":[{"given":"San-Bao","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lu","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib1","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.ijo.0800770","article-title":"Adipose tissue as an endocrine and paracrine organ","volume":"22","author":"Mohamed-Ali","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00041552-200403000-00010","article-title":"Leptin, obesity and cardiovascular disease","volume":"13","author":"Correia","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib3","first-page":"2904","article-title":"Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone","volume":"82","author":"Blum","year":"1997","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2005-871738","article-title":"Human leptin: an adipocyte hormone with weight regulatory and endocrine functions","volume":"5","author":"Considine","year":"2005","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib5","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/01.CIR.0000036864.14101.1B","article-title":"Does leptin cause vascular disease?","volume":"106","author":"Cooke","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib6","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/sj.ijo.0802125","article-title":"Pathways from obesity to hypertension: from the perspective of a vicious triangle","volume":"26","author":"Montani","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib7","first-page":"BR221","article-title":"Human leptin administered intraperitoneally stimulates natriuresis an decreases renal medullary Na+, K+-ATPase activity in the rat-impaired effect in dietary-induced obesity","volume":"8","author":"Beltowski","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib8","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1172\/JCI13143","article-title":"Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity","volume":"108","author":"Konstantinides","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib9","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1001\/jama.287.13.1706","article-title":"Effect of leptin on arterial thrombosis following vascular injury in mice","volume":"287","author":"Bodary","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib10","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.ijo.0801361","article-title":"Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men","volume":"24","author":"Chu","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1076\/apab.109.4.357.4249","article-title":"NGF, BDNF, leptin, and mast cells in human coronary atherosclerosis and metabolic syndrome","volume":"109","author":"Chaldakov","year":"2001","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.STR.30.2.328","article-title":"Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort","volume":"30","author":"Soderberg","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2005.03.048","article-title":"Leptin receptor and functional effects of leptin in human endothelial progenitor cells","volume":"183","author":"Wolk","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib14","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib15","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2337\/diacare.21.5.782","article-title":"Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study","volume":"21","author":"Couillard","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2796.1999.00571.x","article-title":"Leptin is associated with increased risk of myocardial infarction","volume":"246","author":"S\u00f6derberg","year":"1999","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib17","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1161\/hc5001.101061","article-title":"Plasma leptin and the risk of cardiovascular disease in the West Of Scotland Coronary Prevention Study (WOSCOPS)","volume":"104","author":"Wallace","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib18","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/oby.2007.202","article-title":"Leptin and coronary heart disease risk: prospective case control study of British women","volume":"15","author":"Lawlor","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ncpcardio1218","article-title":"Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population","volume":"5","author":"Romero-Corral","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2265.2009.03627.x","article-title":"Leptinemia and its association with stroke and coronary heart disease in the Jackson Heart Study","volume":"72","author":"Liu","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jacc.2008.09.035","article-title":"Leptin and coronary heart disease\u00a0prospective study and systematic review","volume":"53","author":"Sattar","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.amjcard.2007.02.088","article-title":"Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States Population","volume":"100","author":"Sierra-Johnson","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib23","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib24","unstructured":"Wells GA, Shea B, O'Connell D, et\u00a0al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp [cited 01.03.12]."},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib25","doi-asserted-by":"crossref","first-page":"F351","DOI":"10.1136\/adc.2007.133553","article-title":"Environmental tobacco smoke and fetal health: systematic review and meta-analysis","volume":"93","author":"Leonardi-Bee","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2337\/diabetes.48.2.426","article-title":"Leptin promotes aggregation of human platelets via the long form of its receptor","volume":"48","author":"Nakata","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/09537100903377584","article-title":"High plasma levels of adipocytokines are associated with platelet activation in patients with coronary artery disease","volume":"21","author":"Bigalke","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib29","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1126\/science.281.5383.1683","article-title":"Biological action of leptin as an angiogenic factor","volume":"281","author":"Sierra-Honigmann","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression","volume":"394","author":"Lord","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib31","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/01.CIR.0000033219.24717.52","article-title":"Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?","volume":"106","author":"Singhal","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/abbs\/gmq025","article-title":"Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1\/2 and NF- kB","volume":"42","author":"Huang","year":"2010","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.atherosclerosis.2012.10.031","article-title":"Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+\/Akita): apoE(\u2212\/\u2212) mice","volume":"225","author":"Jun","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib34","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacc.2008.05.060","article-title":"Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease","volume":"52","author":"Martin","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.11.069_bib35","doi-asserted-by":"crossref","first-page":"254S","DOI":"10.1038\/oby.2006.319","article-title":"Leptin resistance and obesity","volume":"14","author":"Enriori","year":"2006","journal-title":"Obesity (Silver Spring)"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013007284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013007284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T19:20:22Z","timestamp":1538940022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013007284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0021915013007284"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.11.069","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leptin and coronary heart disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.11.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}